Telemetry Investments, L.L.C. - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 84 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Telemetry Investments, L.L.C. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$69,000
-17.9%
348,501
+87.2%
0.04%
+15.8%
Q3 2018$84,000
-33.9%
186,200
-26.2%
0.04%
-20.8%
Q2 2018$127,000
-66.2%
252,300
+951.2%
0.05%
-62.5%
Q4 2015$376,000–24,000–0.13%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders